Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P28
Within normal range
vs 5Y Ago
-2.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.16% |
| Q3 2025 | 18.43% |
| Q2 2025 | 17.51% |
| Q1 2025 | -180.38% |
| Q4 2024 | 83.94% |
| Q3 2024 | -1495.08% |
| Q2 2024 | 96.55% |
| Q1 2024 | -238.05% |
| Q4 2023 | 55.02% |
| Q3 2023 | -72.13% |
| Q2 2023 | -41.56% |
| Q1 2023 | 42.04% |
| Q4 2022 | -58.83% |
| Q3 2022 | -5.06% |
| Q2 2022 | -21.10% |
| Q1 2022 | -3.75% |
| Q4 2021 | -1.70% |
| Q3 2021 | 3.47% |
| Q2 2021 | 5.18% |
| Q1 2021 | -75.85% |
| Q4 2020 | 7.53% |
| Q3 2020 | -8.24% |
| Q2 2020 | 8.73% |
| Q1 2020 | -17.09% |
| Q4 2019 | 13.42% |
| Q3 2019 | -22.47% |
| Q2 2019 | 11.99% |
| Q1 2019 | 5.38% |
| Q4 2018 | -26.95% |
| Q3 2018 | -3.23% |
| Q2 2018 | 15.97% |
| Q1 2018 | 14.78% |
| Q4 2017 | -17.52% |
| Q3 2017 | -11.19% |
| Q2 2017 | -7.96% |
| Q1 2017 | -11.84% |
| Q4 2016 | -13.04% |
| Q3 2016 | -7.22% |
| Q2 2016 | -358.67% |
| Q1 2016 | -13.29% |